Status:
COMPLETED
Sequenced vs. Integrated Delivery of Treatment for Adolescent Depression and SUD
Lead Sponsor:
Oregon Research Institute
Conditions:
Adolescent
Depression
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether it is more effective to treat adolescents, with diagnoses of both depression and substance use disorder, with a treatment addressing the substance use...
Detailed Description
Comorbidity is a well established aspect of adolescent psychopathology. The majority of adolescents entering treatment have more than one condition. This study will evaluate service delivery methods o...
Eligibility Criteria
Inclusion
- DSM-IV-TR diagnosis of depression, defined as MDD, dysthymia, or substance-induced mood disorder meeting MDD or dysthymia symptom criteria
- DSM-IV-TR diagnosis of one or more non-nicotine SUD
- Some reported illicit drug use in the last 90 days
- 13-17 years of age
- parent or guardian willing to participate in study
- basic English competency (ability to converse in English)
Exclusion
- Current and acute suicidal ideation at the level warranting inpatient treatment
- current psychotic symptoms
- the adolescent's sibling is already participating in the study
- if on psychiatric medications, a significant change in dosage levels in the prior 4 weeks -
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00680966
Start Date
January 1 2008
End Date
June 1 2013
Last Update
March 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Research Institute
Eugene, Oregon, United States, 97403